Suppr超能文献

血浆脑肠肽水平升高与药物治疗外神经性贪食症中的暴食和失控有关。

Increased plasma asprosin levels are associated with overeating and loss of control in drug-free bulimia nervosa.

机构信息

Department of Clinical Psychology, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, 600 Wan Ping Nan Road, Shanghai, 200030, People's Republic of China.

出版信息

Eat Weight Disord. 2022 Oct;27(7):2783-2789. doi: 10.1007/s40519-022-01431-5. Epub 2022 Jun 29.

Abstract

PURPOSE

Abnormalities in appetite hormones have been implicated in bulimia nervosa (BN). Orexigenic hormone asprosin has been reported to be associated with food intake and weight gain, but no relevant studies have yet been reported in BN. This study investigated asprosin concentrations and their association with eating disorder symptoms in patients with BN.

METHODS

This study recruited a total of 26 BN patients and 23 healthy controls (HC). Symptom severity for eating disorders, depression, and anxiety was determined by the Eating Disorder Examination Questionnaire 6.0, Beck Depression Inventory, Version 2, and Beck Anxiety Inventory, respectively. In addition, the study employed sandwich enzyme-linked immunoassay technology to determine plasma asprosin and glucose concentrations in all participants.

RESULTS

The results revealed that plasma asprosin concentrations were significantly higher in BN patients than in HC (P = 0.037), but the difference disappeared after adjusting for the covariate BMI (F = 2.685, P = 0.108). Correlation analysis showed that asprosin concentration was positively correlated with overeating (r = 0.451, P = 0.021) and eating loss of control (r = 0.483, P = 0.012) in BN patients. Linear regression analysis indicated that an increase in asprosin concentration was associated with an increase in the times of overeating (F = 6.303, P = 0.019, R = 0.208). Multiple linear regression showed that increases in asprosin concentration and BDI-II total score could explain the frequent eating loss of control (F = 5.766, P = 0.009, R = 0.334).

CONCLUSIONS

The present study is the first report of plasma asprosin concentration in BN patients and found that overeating and eating loss of control increased with the increase of asprosin concentration. Additionally, asprosin level and degree of depression may explain the frequency of loss of control.

LEVEL OF EVIDENCE

Level III: Evidence obtained from case-control studies.

摘要

目的

食欲激素的异常与神经性贪食症(BN)有关。促食欲激素 asprosin 已被报道与食物摄入和体重增加有关,但在 BN 中尚未有相关研究报道。本研究旨在探讨 BN 患者中 asprosin 浓度及其与饮食障碍症状的关系。

方法

本研究共招募了 26 名 BN 患者和 23 名健康对照者(HC)。采用饮食障碍检查问卷 6.0、贝克抑郁量表第 2 版和贝克焦虑量表分别评估饮食障碍、抑郁和焦虑的严重程度。此外,采用夹心酶联免疫吸附试验技术测定所有参与者的血浆 asprosin 和血糖浓度。

结果

结果显示,BN 患者的血浆 asprosin 浓度明显高于 HC(P = 0.037),但在调整了协变量 BMI 后,差异消失(F = 2.685,P = 0.108)。相关性分析显示,BN 患者的 asprosin 浓度与暴食(r = 0.451,P = 0.021)和进食失控(r = 0.483,P = 0.012)呈正相关。线性回归分析表明,asprosin 浓度的增加与暴食次数的增加相关(F = 6.303,P = 0.019,R² = 0.208)。多元线性回归显示,asprosin 浓度和 BDI-II 总分的增加可以解释进食失控的频繁发生(F = 5.766,P = 0.009,R² = 0.334)。

结论

本研究首次报道了 BN 患者的血浆 asprosin 浓度,并发现暴食和进食失控的发生频率随着 asprosin 浓度的增加而增加。此外,asprosin 水平和抑郁程度可能解释了失控的频率。

证据水平

III 级:来自病例对照研究的证据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验